. The initial 70-nucleotide RNA pool, containing 31 random nucleotides, was constructed as described [R. Singh, J. Valcarcel, M. R. Green, ibid. 268, 1173 (1995 ]. Tobramycin and kanamycin A were covalently linked to cyanogen bromide-activated Sepharose 4B. The RNA pool was dissolved in selection buffer [50 mM tris-HCl (pH 8.3), 250 mM KCl, 2 mM MgCl 2 ), loaded onto a preselection column (0.25 ml of glycine-Sepharose), eluted with two column volumes of selection buffer, and immediately loaded onto a 0.5-ml aminoglycosideSepharose column. Columns were washed with 10 column volumes of selection buffer (rounds 1 to 5), 10 column volumes of buffer with 5 mM competitor aminoglycoside (rounds 6 to 9), or 10 column volumes of buffer with 10 mM competitor (rounds 10 to 14). The competitor aminoglycoside for tobramycin aptamer selection was kanamycin A and vice versa. Bound RNA was eluted with the cognate aminoglycoside (5 mM) and amplified by reverse transcriptase-polymerase chain reaction (RT-PCR) using flanking primers. The PCR products were transcribed into RNA with T7 RNA polymerase and purified by polyacrylamide gel electrophoresis. Pools were subcloned into the plasmid pBluescript (Stratagene) and sequenced after rounds 10, 12, and 14. 6 . One or three copies of the kanamycin A (kan) or the tobramycin (tob) aptamer were cloned into the Nde I site (one copy) or Nde I and Bsa I sites (three copies) of T7 RNA polymerase-driven expression vector pRSETA (Invitrogen) and transformed into a bacterial strain containing an isopropyl ␤-D-thiogalactopyranoside (IPTG)-inducible T7 RNA polymerase. Bacterial strains were grown in liquid culture overnight, induced with 0.1 mM IPTG for 1 hour, and then diluted into medium containing antibiotic and 0.1 mM IPTG. 7. The partial resistance of bl-kan1 to tobramycin is consistent with the fact that the kan aptamer binds both drugs, whereas the tob aptamer is more selective and binds only tobramycin. 8. None of the strains exhibited increased resistance to the unrelated antibiotics tetracycline and gentamicin. 9. M. Kozak, Annu. Rev. Cell Biol. 8, 197 (1992) l of a solution of 40 mM tris-HCl (pH 7.5), 6 mM MgCl 2 , 2 mM spermidine, 10 mM NaCl. After incubation for 1 hour at 37°C, RNA was purified by extraction with phenol and chloroform, precipitated with ethanol, and resuspended in 30 l of H 2 O. Translation reactions were carried out in 10 l containing 5 l of wheat germ extract, 0.8 l of 1 mM amino acid mixture (without methionine), 2 l of RNA transcript as described above, [
35 S]methionine (0.5 l; 1200 Ci/mmol), and 0 to 80 M drug. Reaction mixtures were incubated at 25°C for 15 min and terminated by addition of 2ϫ sample loading buffer. Translation products were separated by electrophoresis on an 18% polyacrylamide gel, visualized by autoradiography, and quantitated by densitometry. 12. Translation repression was more efficient with multiple aptamers than with a single aptamer. Repression was also more efficient when the aptamers were positioned near the 5Ј end of the mRNA. 10 mM H33342 and then cotransfected (Lipofectamine, Gibco-BRL) with 1 g of pSV␤gal or pH2␤gal and 1 g of the luciferase reporter gene pGL3 (Promega). Two hours after transfection H33342 was reapplied to the cells. Twenty-four hours after transfection cells were harvested and cell extracts were prepared. Cell extracts were normalized for total protein (Bradford assay). ␤-Galactosidase and luciferase activities in the extracts were determined relative to standard curves generated with the purified ␤-galactosidase and luciferase enzymes (Promega). 18. In these experiments, H33342 was used instead of H33258 because it is about 10 times more cellpermeable (14 Differential access to cocaine self-administration produced two patterns of drug intake in rats. With 1 hour of access per session, drug intake remained low and stable. In contrast, with 6 hours of access, drug intake gradually escalated over days. After escalation, drug consumption was characterized by an increased early drug loading and an upward shift in the cocaine dose-response function, suggesting an increase in hedonic set point. After 1 month of abstinence, escalation of cocaine intake was reinstated to a higher level than before. These findings may provide an animal model for studying the development of excessive drug intake and the basis of addiction.
A critical problem in drug addiction research is to understand the differences between controlled and uncontrolled drug use, the latter being an essential feature of drug addiction (1, 2) . These two patterns of drug use may be observed simultaneously in different individuals or they may represent successive stages in the same individuals. The transition from drug use to addiction often involves a gradual process of escalated drug intake, whereby an individual's consumption becomes exaggerated with chronic exposure to a drug (2) . Because escalation of drug use defines a common feature of drug addiction, the study of the factors that govern its development may help to explain the transition from drug use to drug addiction. In animal models of drug self-administration, availability plays a role in determining the pattern of drug intake, as suggested by different studies with different drug access conditions (3) . Numerous studies have restricted drug access to a few hours per day and produced a regular and stable pattern of consumption. In contrast, others have shown that, with continuous access to the drug, different patterns of drug intake develop, including the binge-like patterns of psychomotor stimulant use observed in both animals and humans (3, 4) . Unknown, *To whom correspondence should be addressed. Email: aserge@sage.scripps.edu however, are the mechanisms responsible for escalation of drug intake that may set the stage for addiction. Here, we directly assessed the effect of the history of drug use on cocainetaking behavior and have begun to characterize the factors responsible for the development of escalation of cocaine use and its reversal and relapse.
The duration of access to cocaine (250 g per infusion) dramatically influenced intake (5). With short access (ShA), cocaine intake remained stable over time, whereas with long access (LgA), cocaine intake gradually escalated from 71 to 110 infusions (Fig. 1A) . Escalation of cocaine use appeared as early as the first hour of access to the drug (Fig. 1B) , which rules out an acute within-session tolerance (6) . Furthermore, increased cocaine use did not result from an increase in general activity (7) . Within the first hour, the temporal course of cocaine intake was unchanged in ShA rats with repeated testing (Fig. 1C) ; in LgA rats with repeated testing, cocaine intake increased dramatically the first 10 min and then dropped and stabilized at a larger amount (Fig. 1D ). This increased drug-loading behavior may reflect an acquired "need state" for a higher level of cocaine intoxication (1) .
To establish the generality of these observations and to further determine the nature of the changes underlying increased cocaine use, escalated intake was produced in a different experimental condition (8) . Again, changing the duration of drug availability induced two patterns of cocaine intake (Fig. 2, A and B) . Escalation of total cocaine intake showed no sign of stabilization even after 22 sessions of selfadministration ( Fig. 2A) . Moreover, the temporal pattern of cocaine intake in LgA rats peaked in the first 10 min and then dropped to stabilize at an amount higher than that in ShA rats. Therefore, escalated cocaine use is a robust phenomenon that is observable under different experimental conditions.
In the simple reinforcement schedule used here, the cocaine dose-response curve has a negative slope; above a certain threshold dose, an increase in the unit dose produces a proportional decrease in self-infusions (9) . This phenomenon suggests that the animals regulate their intoxication around some endogenous reference or "hedonic set point" (1, 9) . It is possible that escalated cocaine use results from elevation of a hedonic set point, a hypothesis consistent with the dramatic drug-loading behavior described previously (Fig. 1D) . This hypothesis also predicts that the entire dose-response curve should be shifted upward after escalation. Although drug tolerance (or even sensitization) could account for some aspects of increased use, pharmacological tolerance or sensitization usually reflects a change in drug sensitivity that translates into a horizontal shift of the dose-response curve either to the right (tolerance) or to the left (sensitization) (10, 11) .
To test these predictions, we examined a wide range of cocaine doses (12) . Decreasing the dose produced an increase in cocaine self-infusions (Fig. 2C) , a phenomenon that is true for both ShA and LgA rats. This compensatory process ceased abruptly when the dose was too low to maintain responding (that is, when responding for this dose was similar to responding for vehicle, indicated by the broken line in Fig. 2C) . Importantly, the minimum dose able to maintain cocainetaking behavior (31.25 g per infusion) did not differ between groups, suggesting that drug sensitivity was unchanged (Fig. 2C) . In fact, escalated cocaine use produced an upward shift without a horizontal shift in the dose-response curve. At all doses tested above the threshold, LgA rats self-administered more cocaine than ShA rats (Fig. 2D) . This effect did not result from an increase in general activity, because both groups responded similarly for vehicle (12) . These findings suggest that escalated cocaine use results from a change in the hedonic set point for cocaine instead of from a simple change in sensitivity to the drug (1). This change induced by increasing drug availability suggests that an even longer access to the drug could lead to a further increase in set point.
To assess the persistence of escalated cocaine use, drug access was interrupted for 35 days and then restored (13) . In ShA rats, abstinence had no effect on cocaine intake Fig. 1 . Effect of drug availability on cocaine intake (mean Ϯ SEM). (A) In LgA rats (n ϭ 6) but not in ShA rats (n ϭ 7), total cocaine intake started to increase significantly from the fifth session (P Ͻ 0.05; sessions 5 to 12 compared with session 1) and continued to increase thereafter (P Ͻ 0.05; session 5 compared with sessions 10 to 12). (B) During the first hour, LgA rats took progressively more infusions than ShA rats (P Ͻ 0.05; sessions 8, 10, 11, and 12) . (C and D) In LgA rats (D) but not in ShA rats (C), cocaine intake measured at 10, 50, and 60 min increased (P Ͻ 0.05; first session compared with last session). As shown in the inset in (D), this change (last minus first session) was greater the first 10 min (P Ͻ 0.05; compared with the first 10 min). *, P Ͻ 0.05 (Student's t test after appropriate one-way and two-way analysis of variance). In LgA rats (n ϭ 12) but not in ShA rats (n ϭ 12), mean total cocaine intake (Ϯ SEM) started to increase significantly from session 5 (P Ͻ 0.05; sessions 5 to 22 compared with session 1) and continued to increase thereafter (P Ͻ 0.05; session 5 compared with sessions 8 to 10, 12, 13, and 17 to 22) . (B) During the first hour, LgA rats self-administered more infusions than ShA rats during sessions 5 to 8, 11, 12, 14, 15, and 17 to 22 (P Ͻ 0.05). (C) Mean infusion (Ϯ SEM) per cocaine dose tested. LgA rats took significantly more infusions than ShA rats at doses of 31.25, 62.5, 125 , and 250 g per infusion (P Ͻ 0.05). (D) After escalation, LgA rats took more cocaine than ShA rats regardless of the dose (P Ͻ 0.05). *, P Ͻ 0.05 (Student's t test after appropriate one-way and two-way analysis of variance). (Fig. 3) . In contrast, in LgA rats, cocaine intake dropped to the quantity observed in ShA rats after abstinence, indicating a complete recovery from prior increased cocaine use. However, escalated cocaine intake was reinstated by reexposing rats to the LgA regimen. In the same rats, reinstatement of escalated cocaine intake was more dramatic than when it was originally established (compare Fig. 3 , left and right). This suggests that, although abstinence promotes a short-lived return to previous levels of use, a history of drug escalation facilitates the relapse. The return of cocaine use to baseline during abstinence is reminiscent of a reversal of tolerance; however, the more dramatic escalation observed during reinstatement is more consistent with an allostatic dysregulation in hedonic set point (1) .
This study demonstrates the existence of two patterns of cocaine-taking behavior. Rats allowed short access to cocaine maintained a stable and low intake for many weeks, and this demonstrates that self-administering a drug repeatedly does not lead obligatorily to a process of escalated use analogous to that described in human drug addicts. This observation shows the limitations of equating drug-taking behavior per se with drug addiction and of analyzing drug addiction only in terms of the positive-reinforcing effects of a drug (1) . Indeed, positive-reinforcement analyses explain how behavior is initiated and maintained by a drug but do not explain why an individual self-administers a particular amount of drug and why such an amount may or may not change over time.
In this context, the escalation in drug intake observed in rats that had longer access to cocaine (6 hours) may offer a better animal model of the transition of drug use to drug addiction. Escalated cocaine use produced an increase in drug loading and an upward shift in the cocaine dose-effect function, suggesting an increase in hedonic set point as a potential mechanism for increased drug use. Animals, and perhaps human addicts, may take more cocaine after escalated intake not because they are simply tolerant to its rewarding effects but because they are trying to reach and then to maintain a higher state of intoxication. Certainly, tolerance, as classically defined, may contribute to this allostatic dysregulation; however, the current hypothesis is that an increase in hedonic set point would characterize the transition to the addicted state (1) .
Finally, the temporal course of escalated drug use suggests that the "switch mechanism" of the transition to drug addiction may be gradual rather than abrupt. This is consistent with the slow accumulation of some drug-responsive gene products in the brain described recently during chronic exposure to cocaine (14) . As shown by the dramatic reinstatement of escalated cocaine use after abstinence, part of these modifications are long lasting. Analysis of the brain changes responsible for the escalation in self-administration of cocaine observed in this animal model may help to explain the chronic, relapsing nature of drug addiction. Fig. 3 . Relapse to escalated cocaine use after abstinence. During the initiation phase (left), escalated cocaine use in LgA rats (n ϭ 5) was significant after session 19 (P Ͻ 0.05). During reinstatement (right), escalated cocaine intake in LgA rats was fully reinstated after only six reinstatement sessions (P Ͻ 0.05). The session-by-session fluctuation observed in ShA rats (n ϭ 6) during reinstatement was not significant (simple main effect). *, P Ͻ 0.05 (Student's t test after appropriate one-way and two-way analysis of variance).
